Myriam Bensemlali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Myriam Bensemlali has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Damien Bonnet
Centre de Référence Malformations Cardiaques Congénitales Complexes (M3C), Hôpital Universitaire Necker-Enfants Malades, AP-HP, 75015 Paris, France; Université de Paris Cité, 75006 Paris, France
5 shared publications Fanny Bajolle
Hôpital Necker Enfants malades,APHP,Centre de référence Malformations Cardiaques Congénitales Complexes - M3C,Paris,France
4 shared publicationsLaurent Fermont
Hôpital Necker Enfants malades,APHP,Centre de référence Malformations Cardiaques Congénitales Complexes - M3C,Paris,France
4 shared publicationsDamien Bonnet
Unité Médico-Chirurgicale de Cardiologie Congénitale et Pédiatrique, Centre de Référence Malformations Cardiaques Congénitales Complexes, M3C, Hôpital Necker Enfants Malades, Assistance publique hôpitaux de Paris, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France
3 shared publications- Francesca Raimondi
Congenital Cardiology Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy
3 shared publications Jérôme Le Bidois
Unité Médico-Chirurgicale de Cardiologie Congénitale et Pédiatrique, Centre de Référence Malformations Cardiaques Congénitales Complexes, M3C, Hôpital Necker Enfants Malades, Assistance publique hôpitaux de Paris, Paris, France
3 shared publications
Latest Publications
- Open Access
- 10 June 2019
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 57 (1) , 46-53
Nakata index above 1500 mm2/m2 predicts death in absent pulmonary valve syndrome
OBJECTIVES: Absent pulmonary valve syndrome is a rare congenital heart disease with severe airway compression due to dilatation of the pulmonary arteries (PAs). We investigated risk factors for death and prolonged mechanical ventilation (>7 days) and a threshold PA size for these outcomes.METHODS: This retrospective 2-centre cohort study included 68 patients with complete repair between January 1996 and December 2015.RESULTS: Median age at repair was 3.9 months (1.3–8.7 months), and median weight was 5 kg (4–7 kg). The mortality rate before hospital discharge was 12%, and the mortality rate at last follow-up was 19%. In multivariable analysis, risk factors for death were higher Nakata index [hazard ratio (HR) 1.001, 95% confidence interval (CI) 1.001–1.002; P < 0.001] and lower SpO2 (HR 1.06, 95% CI 1.02–1.09; P = 0.002). The accuracy of the Nakata index to predict death was excellent (area under the curve at 6 months: 0.92; P = 0.010). A Nakata index above 1500 mm2/m2 predicted mortality at 6 months with a sensitivity of 98% and a specificity of 82%. Twenty-five patients (37%) had prolonged mechanical ventilation. The only multivariable risk factor for prolonged ventilation was lower weight at repair (odds ratio 2.9, 95% CI 1.3–6.7; P = 0.008). Neither PA plasty nor the LeCompte manoeuvre had a protective effect on mortality or prolonged ventilation. A Nakata index above 1500 mm2/m2 remained a risk factor for mortality (P = 0.022) in patients who had a PA plasty or the LeCompte manoeuvre.CONCLUSIONS: In patients with absent pulmonary valve syndrome, the Nakata index predicts mortality with a cut-off of 1500 mm2/m2. Lower weight at repair is the only multivariable risk factor for prolonged ventilation. Neither PA plasty nor the LeCompte manoeuvre had a protective effect on these outcomes.
- 10 June 2019
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 57 (1) , 46-53
Open AccessNakata index above 1500 mm2/m2 predicts death in absent pulmonary valve syndrome
OBJECTIVES: Absent pulmonary valve syndrome is a rare congenital heart disease with severe airway compression due to dilatation of the pulmonary arteries (PAs). We investigated risk factors for death and prolonged mechanical ventilation (>7 days) and a threshold PA size for these outcomes.METHODS: This retrospective 2-centre cohort study included 68 patients with complete repair between January 1996 and December 2015.RESULTS: Median age at repair was 3.9 months (1.3–8.7 months), and median weight was 5 kg (4–7 kg). The mortality rate before hospital discharge was 12%, and the mortality rate at last follow-up was 19%. In multivariable analysis, risk factors for death were higher Nakata index [hazard ratio (HR) 1.001, 95% confidence interval (CI) 1.001–1.002; P < 0.001] and lower SpO2 (HR 1.06, 95% CI 1.02–1.09; P = 0.002). The accuracy of the Nakata index to predict death was excellent (area under the curve at 6 months: 0.92; P = 0.010). A Nakata index above 1500 mm2/m2 predicted mortality at 6 months with a sensitivity of 98% and a specificity of 82%. Twenty-five patients (37%) had prolonged mechanical ventilation. The only multivariable risk factor for prolonged ventilation was lower weight at repair (odds ratio 2.9, 95% CI 1.3–6.7; P = 0.008). Neither PA plasty nor the LeCompte manoeuvre had a protective effect on mortality or prolonged ventilation. A Nakata index above 1500 mm2/m2 remained a risk factor for mortality (P = 0.022) in patients who had a PA plasty or the LeCompte manoeuvre.CONCLUSIONS: In patients with absent pulmonary valve syndrome, the Nakata index predicts mortality with a cut-off of 1500 mm2/m2. Lower weight at repair is the only multivariable risk factor for prolonged ventilation. Neither PA plasty nor the LeCompte manoeuvre had a protective effect on these outcomes.
- 1 October 2017
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 110 (10) , 517-524
Percutaneous pulmonary Melody® valve implantation in small conduits
- 1 October 2017
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 110 (10) , 517-524
Percutaneous pulmonary Melody® valve implantation in small conduits
- 1 September 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (5) , 10-11
Percutaneous pulmonary Melody valve implantation in conduit below 16mm
- 1 September 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (5) , 10-11
Percutaneous pulmonary Melody valve implantation in conduit below 16mm
- 26 May 2016
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 27 (2) , 344-353
Neonatal management and outcomes of prenatally diagnosed CHDs
Objectives: The aim of this study was to determine the probability of intervention at birth after prenatal diagnosis of CHD.Methods: A 10-year retrospective study including all foetuses with a prenatally diagnosed CHD and those delivered in a tertiary-care cardiac centre between January, 2002 and December, 2011 was carried out. Patients were classified into eight groups according to the anticipated risk of neonatal intervention.Results: The need for urgent intervention and/or PGE1 infusion within the first 48 hours of life was 47% (n=507/1080): 72% (n=248) for CHD at risk for a Rashkind procedure, 77% (n=72) for CHD with ductal-dependent pulmonary flow, 13% (n=22) for CHD with potentially ductal-dependent pulmonary flow, 94% (n=62) for CHD with ductal-dependent systemic flow, 29% (n=88) for CHD with potentially ductal-dependant systemic flow, 50% (n=4) for total anomalous pulmonary venous connection, and 17% (n=1) for CHD with atrio-ventricular block. In all, 34% of the patients received PGE1 infusion and 21.4% underwent urgent catheter-based or surgical interventions; 10% of patients without anticipated risk (n=10) underwent an early intervention; 6.7% (n=73) of the patients died; and 55% (n=589) had an intervention before discharge from hospital.Conclusion: Half of the neonates with foetal CHD benefited from an urgent intervention or PGE1 infusion at birth. We recommend scheduled delivery and in utero transfer for transposition of the great arteries, double-outlet right ventricle with sub-pulmonary ventricular septal defect, total anomalous pulmonary venous connection, CHD with atrio-ventricular block with heart rate <50, all ductal-dependant lesions, and CHD with potentially ductal-dependant systemic flow.
- 26 May 2016
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 27 (2) , 344-353
Neonatal management and outcomes of prenatally diagnosed CHDs
Objectives: The aim of this study was to determine the probability of intervention at birth after prenatal diagnosis of CHD.Methods: A 10-year retrospective study including all foetuses with a prenatally diagnosed CHD and those delivered in a tertiary-care cardiac centre between January, 2002 and December, 2011 was carried out. Patients were classified into eight groups according to the anticipated risk of neonatal intervention.Results: The need for urgent intervention and/or PGE1 infusion within the first 48 hours of life was 47% (n=507/1080): 72% (n=248) for CHD at risk for a Rashkind procedure, 77% (n=72) for CHD with ductal-dependent pulmonary flow, 13% (n=22) for CHD with potentially ductal-dependent pulmonary flow, 94% (n=62) for CHD with ductal-dependent systemic flow, 29% (n=88) for CHD with potentially ductal-dependant systemic flow, 50% (n=4) for total anomalous pulmonary venous connection, and 17% (n=1) for CHD with atrio-ventricular block. In all, 34% of the patients received PGE1 infusion and 21.4% underwent urgent catheter-based or surgical interventions; 10% of patients without anticipated risk (n=10) underwent an early intervention; 6.7% (n=73) of the patients died; and 55% (n=589) had an intervention before discharge from hospital.Conclusion: Half of the neonates with foetal CHD benefited from an urgent intervention or PGE1 infusion at birth. We recommend scheduled delivery and in utero transfer for transposition of the great arteries, double-outlet right ventricle with sub-pulmonary ventricular septal defect, total anomalous pulmonary venous connection, CHD with atrio-ventricular block with heart rate <50, all ductal-dependant lesions, and CHD with potentially ductal-dependant systemic flow.
- 1 May 2016
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 109 (5) , 330-336
Associated genetic syndromes and extracardiac malformations strongly influence outcomes of fetuses with congenital heart diseases
- 1 May 2016
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 109 (5) , 330-336
Associated genetic syndromes and extracardiac malformations strongly influence outcomes of fetuses with congenital heart diseases
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 99
0228: Impact of the precision of prenatal diagnostic of congenital heart diseases on perinatal and long-term management
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 99
0228: Impact of the precision of prenatal diagnostic of congenital heart diseases on perinatal and long-term management
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 104-105
0535: A novel approach to exploration of complex congenital heart diseases through 3D CT scans
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 104-105
0535: A novel approach to exploration of complex congenital heart diseases through 3D CT scans
- 1 November 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (4) , 265
P7 Impact of precision prenatal diagnostic of congenital heart diseases on perinatal and long-term management
- 1 November 2015
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 7 (4) , 265
P7 Impact of precision prenatal diagnostic of congenital heart diseases on perinatal and long-term management